Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers.

导出 LinkOut

翻译打印收藏纠错

作者： Kelly C,Gast ^[1] ; Paul V,Viscuse ^[1] ; Somaira,Nowsheen ^[2] ; Tufia C,Haddad ^[3] ; Robert W,Mutter ^[4] ; Andrea E,Wahner Hendrickson ^[3] ; Fergus J,Couch ^[5] ; Kathryn J,Ruddy ^[6]

作者单位： Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education, Rochester, MN, USA. ^[1] Mayo Clinic Graduate School of Biomedical Sciences, Medical Scientist Training Program, Mayo Clinic School of Medicine, Rochester, MN, USA. ^[2] Department of Oncology, Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55095, USA. ^[3] Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. ^[4] Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. ^[5] Department of Oncology, Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55095, USA. Ruddy.kathryn@mayo.edu. ^[6]

关键词 BRCA mutation Cardio-oncology Chemotherapy cardiotoxicity Radiation cardiotoxicity

DOI 10.1007/s11936-018-0609-z

PMID 29497862

发布时间 2021-07-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交